Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

IF 20.6 1区医学 Q1 RHEUMATOLOGY

Annals of the Rheumatic Diseases Pub Date : 2025-10-22 DOI:10.1016/j.ard.2025.09.012

Elpida Phithak, Fredrik N Albach, Ioanna Minopoulou, Robert Biesen, Arnd Kleyer, Edgar Wiebe, Elise Siegert, Veronika Scholz, Marie Rehm, Qingyu Cheng, Arne Sattler, Stefano Bianco, Anja Fleischmann, Kay-Geert Hermann, Thula Walter-Rittel, Moritz Wagner, Jan Zernicke, Vincent Casteleyn, Martin Nielsen, Thomas Rose, Antonia Busse, Marie Luise Hütter-Krönke, Ulrich Keller, Udo Schneider, Leona Kawelke, Nikolas Ruffer, Werner Stenzel, Gerhard Krönke, David Simon, Tobias Alexander

引用次数: 0

查看原文本刊更多论文

特司他抗诱导的难治性抗jo -1抗合成酶综合征的快速缓解。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of the Rheumatic Diseases 医学-风湿病学

CiteScore

35.00

自引率

9.90%

发文量

3728

审稿时长

1.4 months

期刊介绍： Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.